Markku Jalkanen

hideThis article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (December 2017) (Learn how and when to remove this template message) The topic of this article may not meet Wikipedia's notability guideline for biographies. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources:  –  ·  ·  · scholar · JSTOR (December 2017) (Learn how and when to remove this template message) This biographical article is written like a résumé. Please by revising it to be neutral and encyclopedic. (December 2017) (Learn how and when to remove this template message)

Markku Jalkanen (born 1954) is a scientist, biotech entrepreneur and businessman from Turku, Finland. He is the CEO of Faron Pharmaceuticals, a Finnish biopharmaceutical company listed on London's Alternative Investment Market. Jalkanen was the founding CEO and President of Biotie Therapies, the first publicly traded biotech-company in Finland.^[1] He is an advisor for the Finnish life-science fund, Inveni Capital.^[2]

Education and career[]

Jalkanen obtained a master's degree in Medical Biochemistry from the University of Kuopio, a PhD in Medical Biochemistry from the University of Turku and completed his post-doctoral training at Stanford University.^[1]

Jalkanen has received awards for his scientific research and business achievements: The Anders Jahre Medical Prize for Younger Researchers in 1993,^[3] The Developer of Turku Award of 1993,^[4] The 1994 Academic Publicity Award,^[4] Teacher of the Year 1996 of the University of Turku,^[4] The Inno-Suomi Award in 1998 for the entrepreneurial industrialization of academic discoveries (BioTie) ^[5]

Jalkanen pioneered the Finnish biotech development while being the first Director (Professor) of Turku Biotechnology Center within BioCity community in Turku.^[6] He has published over 130 peer reviewed scientific publications and has a -index of >45.^[4]

References[]